Period Ending | Feb 3, 2012 | Oct 28, 2011 | Jul 29, 2011 | Apr 29, 2011 |
---|
Total Revenue
|
16,031,000
|
15,365,000
|
15,658,000
|
15,017,000
| Cost of Revenue | 12,646,000 | 11,896,000 | 12,133,000 | 11,585,000 | |
Gross Profit
|
3,385,000
|
3,469,000
|
3,525,000
|
3,432,000
| |
|
Operating Expenses |
|
Research Development | 236,000 | 220,000 | 205,000 | 195,000 |
|
Selling General and Administrative | 2,218,000 | 2,107,000 | 2,174,000 | 2,025,000 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
931,000
|
1,142,000
|
1,146,000
|
1,212,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 1,098,000 | 1,072,000 | 1,091,000 | 1,170,000 |
|
Interest Expense | 191,000 |
-
|
-
|
-
|
|
Income Before Tax | 907,000 | 1,072,000 | 1,091,000 | 1,170,000 |
|
Income Tax Expense | 143,000 | 179,000 | 201,000 | 225,000 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 764,000 | 893,000 | 890,000 | 945,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
764,000
|
893,000
|
890,000
|
945,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
764,000
|
893,000
|
890,000
|
945,000
|
|